As noted above, the thing about walking pneumonia that distinguishes it from traditional pneumonia is the relative mildness ...

In connection with the start of the phase 3 trials of PCV21, Sanofi has expanded its alliance with South Korea-based SK Bio, ...

French pharma major Sanofi says it has entered into a new chapter of the collaboration with South Korean firm SK bioscience ...

Experts highlighted that India is only in the early stages of making progress, and so far, solutions have been found for just ...

Antimicrobial resistance and serotypes in Streptococcus pneumoniae have been evolving with the widespread use of antibiotics and the introduction of pneumococcal conjugate vaccines (PCV).

VMPL Trichy Tamil Nadu [India] 9 Pneumonia is a widespread lung disease across the world Yet awareness about pneumonia among ...

Objective: To compare the safety and efficacy of clarithromycin and amoxicillin/clavulanic acid in patients with community-acquired pneumonia due to penicillin ...

Despite decades of public health vaccination programs, invasive pneumococcal disease (IPD) continues to inflict a substantial burden of disease, primarily due to Streptococcus pneumoniae serotypes ...

At a recent Society for Leukocyte Biology meeting, three Jacobs School of Medicine and Biomedical Sciences researchers — two doctoral students and a faculty member, all from the Department of ...

Walking pneumonia differs from other respiratory infections like flu or cold because it quickly settles in the chest and can ...

In this cluster-randomized controlled trial, it was found that a pneumococcal conjugate vaccine (PCV) schedule involving a ...